Related Experiment Video
Updated: Jul 23, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
Modeling Retinitis Pigmentosa with Patient-Derived iPSCs
Yeh Chwan Leong1, Jane C Sowden2
1Stem Cells and Regenerative Medicine Section, UCL Great Ormond Street Institute of Child Health, University College London and NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK.
Patient-derived induced pluripotent stem cells (iPSCs) offer a superior model for studying retinitis pigmentosa (RP) compared to animal models. This approach aids in understanding photoreceptor death and developing new therapies for retinal degeneration.
Area of Science:
- Ophthalmology
- Genetics
- Stem Cell Biology
Background:
- Retinitis pigmentosa (RP) is a group of inherited retinal diseases causing progressive vision loss and blindness.
- Photoreceptor degeneration is the primary pathology in RP, necessitating a deeper understanding for therapeutic development.
- Existing animal models for RP have limitations in fully recapitulating human disease mechanisms.
Conclusions:
- Induced pluripotent stem cells provide a powerful and increasingly valuable tool for modeling retinitis pigmentosa.
- iPSC technology facilitates personalized medicine approaches for RP by using patient-specific cells.
- Continued refinement of iPSC-based models is essential for advancing RP therapies and combating blindness.
More Related Videos
Related Concept Videos
iPS Cell Differentiation
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells

